Glucocorticoids activate Epstein Barr virus lytic replication through the upregulation of immediate early BZLF1 gene expression

Brain, Behavior, and Immunity

Volumn 24, Issue 7, 2010, Pages 1089-1096

  Yang, Eric V ^a   Webster Marketon, Jeanette I ^a   Chen, Min ^a   Lo, Kwok Wai ^b   Kim, Seung jae ^a   Glaser, Ronald ^a,c  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Epstein Barr virus; Glucocorticoid receptor; Glucocorticoids; Herpesvirus reactivation; Psychological stress

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE; IMMEDIATE EARLY PROTEIN BZLF1; MESSENGER RNA; VIRUS DNA;

ARTICLE; BZLF1 GENE; DRUG ACTIVITY; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENETIC CODE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; VIRUS GENE; VIRUS REPLICATION;

EID: 80053464095     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2010.04.013     Document Type: Article

References (41)

1. Bauer G. Induction of Epstein-Barr virus early antigens by corticosteroids: Inhibition by TPA and retinoic acid. Int. J. Cancer 1983, 31:291-295.
2. Buchwald D., Umali P., Umali J., Kith P., Pearlman T., Komaroff A.L. Chronic fatigue and the chronic fatigue syndrome: prevalence in a Pacific Northwest health care system. Ann. Intern. Med. 1995, 123:81-88.
3. Cacioppo J., Kiecolt-Glaser J., Malarkey W., Laskowski B., Rozlog L., Poehlmann K., Burleson M., Glaser R. Autonomic and glucocorticoid associations with the steady-state expression of latent Epstein-Barr virus. Horm. Behav. 2002, 42:32-41.
4. Cheung S.T., Huang D.P., Hui A.B., Lo K.W., Ko C.W., Tsang Y.S., Wong N., Whitney B.M., Lee J.C. Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int. J. Cancer 1999, 83:121-126.
5. Chrousos G.P., Loriaux D.L., Brandon D., Shull J., Renquist D., Hogan W., Tomita M., Lipsett M.B. Adaptation of the mineralocorticoid target tissues to the high circulating cortisol and progesterone plasma levels in the squirrel monkey. Endocrinology 1984, 115:25-32.
6. Chrousos G.P., Renquist D., Brandon D., Eil C., Pugeat M., Vigersky R., Cutler G.B., Loriaux D.L., Lipsett M.B. Glucocorticoid hormone resistance during primate evolution: receptor-mediated mechanisms. Proc. Natl. Acad. Sci. 1982, 79:2036-2040.
7. Duma D., Jewell C.M., Cidlowski J.A. Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification. J. Steroid Biochem. Mol. Biol. 2006, 102:11-21.
8. Esterling B.A., Antoni M.H., Schneiderman N., Carver C.S., LaPerriere A., Ironson G., Klimas N.G., Fletcher M.A. Psychosocial modulation of antibody to Epstein-Barr viral capsid antigen and human herpesvirus type-6 in HIV-1-infected and at-risk gay men. Psychosom. Med. 1992, 54:354-371.
9. Falk K.I., Ernberg I. Demethylation of the Epstein-Barr virus origin of lytic replication and of the immediate early gene BZLF1 is DNA replication independent. Brief report. Arch. Virol. 1999, 144:2219-2227.
10. Glaser R., Kiecolt-Glaser J.K. Stress-induced immune dysfunction: implications for health. Nature reviews. Immunology 2005, 5:243-251.
11. Glaser R., Kutz L.A., MacCallum R.C., Malarkey W.B. Hormonal modulation of Epstein-Barr virus replication. Neuroendocrinology 1995, 62:356-361.
12. Glaser R., O'Neill F.J. Hybridization of Burkitt lymphoblastoid cells. Science 1972, 176:1245-1247.
13. Glaser R., Padgett D.A., Litsky M.L., Baiocchi R.A., Yang E.V., Chen M., Yeh P.E., Klimas N.G., Marshall G.D., Whiteside T., Herberman R., Kiecolt-Glaser J., Williams M.V. Stress-associated changes in the steady-state expression of latent Epstein-Barr virus: implications for chronic fatigue syndrome and cancer. Brain Behav. Immun. 2005, 19:91-103.
14. Glaser R., Pearl D.K., Kiecolt-Glaser J.K., Malarkey W.B. Plasma cortisol levels and reactivation of latent Epstein-Barr virus in response to examination stress. Psychoneuroendocrinology 1994, 19:765-772.
15. Glaser R., Pearson G.R., Bonneau R.H., Esterling B.A., Atkinson C., Kiecolt-Glaser J.K. Stress and the memory T-cell response to the Epstein-Barr virus in healthy medical students. Health Psychol.: Off. J. Div. Health Psychol. Am. Psychol. Assoc. 1993, 12:435-442.
16. Glaser R., Pearson G.R., Jones J.F., Hillhouse J., Kennedy S., Mao H.Y., Kiecolt-Glaser J.K. Stress-related activation of Epstein-Barr virus. Brain Behav. Immun. 1991, 5:219-232.
17. Glaser R., Rice J., Sheridan J., Fertel R., Stout J., Speicher C.E., Pinsky D., Kotur M., Post A., Beck M., Kiecolt-Glaser J.K. Stress-related immune suppression: health implications. Brain Behav. Immun. 1987, 1:7-20.
18. Glaser R., Zhang H.Y., Yao K.T., Zhu H.C., Wang F.X., Li G.Y., Wen D.S., Li Y.P. Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. Proc. Natl. Acad. Sci. Am. 1989, 86:9524-9528.
19. Jason L.A., Taylor R.R., Kennedy C.L., Jordan K., Song S., Johnson D.E., Torres S.R. Chronic fatigue syndrome: sociodemographic subtypes in a community-based sample. Eval. Health Prof. 2000, 23:243-263.
20. Joncas J., Boucher J., Boudreault A., Granger-Julien M. Effect of hydrocortisone on cell viability, Epstein-Barr virus genome expression and interferon synthesis in human lymphoblastoid cell lines. Cancer Res. 1973, 33:2142-2148.
21. Joncas J., Leyritz M. The effect of hydrocortisone and bromodeoxyuridine (BUdR) on the Epstein-Barr herpes virus in human lymphoblastoid cell lines. Rev. Can. Biol. 1974, 33:135-147.
22. Kimura H., Morita M., Yabuta Y., Kuzushima K., Kato K., Kojima S., Matsuyama T., Morishima T. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J. Clin. Microbiol. 1999, 37:132-136.
23. Klimas N.G., Salvato F.R., Morgan R., Fletcher M.A. Immunologic abnormalities in chronic fatigue syndrome. J. Clin. Microbiol. 1990, 28:1403-1410.
24. Kupfer S.R., Summers W.C. Identification of a glucocorticoid-responsive element in Epstein-Barr virus. J. Virol. 1990, 64:1984-1990.
25. Laux G., Freese U.K., Fischer R., Polack A., Kofler E., Bornkamm G.W. TPA-inducible Epstein-Barr virus genes in Raji cells and their regulation. Virology 1988, 162:503-507.
26. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
27. Lutgendorf S.K., Antoni M.H., Kumar M., Schneiderman N. Changes in cognitive coping strategies predict EVA-antibody titre change following a stressor disclosure induction. J. Psychosom. Res. 1994, 38:63-78.
28. Magrath I.T., Pizzo P.A., Novikova L., Levine A.S. Enhancement of Epstein-Barr virus replication in producer cell lines by a combination of low temperature and corticosteroids. Virology 1979, 97:477-481.
29. Mehta S.K., Crucian B., Pierson D.L., Sams C., Stowe R.P. Monitoring immune system function and reactivation of latent viruses in the Artificial Gravity Pilot Study. J. Gravit. Physiol.: A J. Int. Soc. Gravit. Physiol. 2007, 14:P21.
30. Mehta S.K., Pierson D.L., Cooley H., Dubow R., Lugg D. Epstein-Barr virus reactivation associated with diminished cell-mediated immunity in Antarctic expeditioners. J. Med. Virol. 2000, 61:235-240.
31. Payne D.A., Mehta S.K., Tyring S.K., Stowe R.P., Pierson D.L. Incidence of Epstein-Barr virus in astronaut saliva during spaceflight. Aviat. Space Environ. Med. 1999, 70:1211.
32. Pierson D.L., Stowe R.P., Phillips T.M., Lugg D.J., Mehta S.K. Epstein-Barr virus shedding by astronauts during space flight. Brain Behav. Immun. 2005, 19:235-242.
33. Prachova K., Roubal J. Effects of hydrocortisone on the synthesis of Epstein-Barr virus antigens in P3HR-1 cells. Acta Virol. 1981, 25:163-166.
34. Rabin B.S. Stress, Immune Function, and Health: The Connection 1999, Wiley-Liss, New York.
35. Sarid O., Anson O., Yaari A., Margalith M. Epstein-Barr virus specific salivary antibodies as related to stress caused by examinations. J. Med. Virol. 2001, 64:149-156.
36. Schuster C., Chasserot-Golaz S., Urier G., Beck G., Sergeant A. Evidence for a functional glucocorticoid responsive element in the Epstein-Barr virus genome. Mol. Endocrinol. (Baltimore Md) 1991, 5:267-272.
37. Spanjaard R.A., Chin W.W. Reconstitution of ligand-mediated glucocorticoid receptor activity by trans-acting functional domains. Mol. Endocrinol. 1993, 7:12-16.
38. Speck S.H., Chatila T., Flemington E. Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene. Trends Microbiol. 1997, 5:399-405.
39. Stowe R.P., Pierson D.L., Feeback D.L., Barrett A.D. Stress-induced reactivation of Epstein-Barr virus in astronauts. NeuroImmunoModulation 2000, 8:51-58.
40. Ye J., Gradoville L., Daigle D., Miller G. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists. J. Virol. 2007, 81:9279-9291.
41. Zhang H.Y., Qu G., Deng Z.W., Yao T.H., Glaser R. Epstein-Barr virus DNA in nasopharyngeal biopsies. Virus Res. 1989, 12:53-59.